BIOCARTIS GROUP NV

BCART
Real-time Quote. Real-time  - 10/22 11:35:22 am
4.07EUR +4.49%

Turn to zoom
Prev.3.8950
Open3.9700
High4.0750
Low3.9000
Volume68 460
Latest news
10/12
10/12
09/23
09/23
Chart BIOCARTIS GROUP NV
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralBearish
Resistance4,074,464,28
Spread/Res.0,00%-8,7%-4,9%
Spread/Supp.4,4%9,4%9,1%
Support3,903,723,73
Financials
Sales 2021 52,9 M 61,6 M 61,6 M
Net income 2021 -81,0 M -94,3 M -94,3 M
Net Debt 2021 106 M 123 M 123 M
P/E ratio 2021 -3,06x
Yield 2021 -
Capitalization 234 M 272 M 273 M
EV / Sales 2021 6,43x
EV / Sales 2022 5,33x
Nbr of Employees 484
Free-Float 86,4%
Company
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection...

>> Read more
Sector :
Medical Equipment
Calendar :
2021-11-10 Sales and Revenue Release
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 4,07 €
Average target price 6,50 €
Spread / Average Target 59,7%